OMS Energy Technologies Inc. (OMSE)

NASDAQ: OMSE · Real-Time Price · USD

6.82

-0.39 (-5.41%)

At close: Aug 1, 2025, 4:00 PM

7.19

+0.37 (5.43%)

After-hours: Aug 1, 2025, 5:50 PM EDT

CTI BioPharma Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	203.61	181.45	97.46	56.72
Revenue Growth (YoY)	12.21%	86.17%	71.83%	-
Cost of Revenue	134.62	127.68	69.42	42.77
Gross Profit	68.99	53.77	28.04	13.95
Selling, General & Admin	8.25	8.5	6.96	5.49
Other Operating Expenses	0.34	1.59	1.04	1.04
Operating Expenses	9.15	10.41	8.18	6.8
Operating Income	59.83	43.36	19.86	7.15
Interest Expense	-0.25	-1.07	-1.91	-0.89
Interest & Investment Income	0.34	0.13	0.24	0.09
Earnings From Equity Investments	-	-	3.43	3.4
Currency Exchange Gain (Loss)	-0.49	-0.27	-0.65	-
Other Non Operating Income (Expenses)	0.85	0.61	0.63	0.68
EBT Excluding Unusual Items	60.28	42.76	21.59	10.44
Gain (Loss) on Sale of Assets	-0.11	0.36	0.02	-
Other Unusual Items	-	49.43	-	-
Pretax Income	60.17	92.54	21.61	10.44
Income Tax Expense	13.19	8.08	9.19	0.75
Earnings From Continuing Operations	46.98	84.46	12.42	9.69
Minority Interest in Earnings	-2.16	-1.72	-0.78	-1.22
Net Income	44.82	82.75	11.65	8.47
Preferred Dividends & Other Adjustments	-	1.87	-	-
Net Income to Common	44.82	80.88	11.65	8.47
Net Income Growth	-45.84%	610.46%	37.59%	-
Shares Outstanding (Basic)	38	37	91	90
Shares Outstanding (Diluted)	38	37	91	90
Shares Change (YoY)	2.50%	-59.28%	0.70%	-
EPS (Basic)	1.18	2.19	0.13	0.09
EPS (Diluted)	1.18	2.19	0.13	0.09
EPS Growth	-45.94%	1605.60%	42.79%	-
Free Cash Flow	37.64	16.72	27.96	9.78
Free Cash Flow Per Share	0.99	0.45	0.31	0.11
Gross Margin	33.88%	29.63%	28.77%	24.60%
Operating Margin	29.39%	23.90%	20.38%	12.61%
Profit Margin	22.01%	44.57%	11.95%	14.92%
Free Cash Flow Margin	18.49%	9.21%	28.69%	17.24%
EBITDA	62.55	47.42	20.78	7.6
EBITDA Margin	30.72%	26.14%	21.32%	13.40%
D&A For EBITDA	2.72	4.06	0.91	0.45
EBIT	59.83	43.36	19.86	7.15
EBIT Margin	29.39%	23.90%	20.38%	12.61%
Effective Tax Rate	21.92%	8.73%	42.52%	7.22%
Revenue as Reported	203.61	181.45	97.46	56.72

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q